Survival estimates may help patients with BRCA mutations choose
best risk reduction strategy
Prophylactic mastectomy when aged 25 years plus
prophylactic oophorectomy when aged 40 years may be the most effective risk
reduction strategy for women with BRCA mutations; however, substituting
mammography plus MRI screening for prophylactic mastectomy appeared to offer
comparable survival outcomes, according to data from a simulation model.
FULL STORY